Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Check LXGTF Management Team: https://lexingtonbiosciences.com/company/management/
a good reason to have a breaktrough now!
Good morning!
this week must be some breakthrough
Essential materials for new investors!!!
just formalities
true, things are settled correctly
Well said Pac, love your realistic way :)
it takes time and then BUUM! The excitement is then greater :Ž)
Just rolling all day, we need something to rock here
wow still near 50%
I am very curious what the Power Hour can do today?!
WAS REALLY NICE NEWS HERE: Lexington Hires Medical Device Reimbursement Experts
http://www.otcmarkets.com/stock/LXGTF/news/Lexington-Hires-Medical-Device-Reimbursement-Experts?id=177513&b=y
CHECK MORE HERE!!! Lexington’s President Eric Willis comments, “After nine months of concerted effort by our design and production team, the arrival of our first human-use HeartSentry devices allows us to accelerate our plans to move ahead with our pilot study. Diablo Clinical Research is a proven and respected establishment with the capability to launch our research program efficiently and cost-effectively. They have been extremely helpful in the determination process which has led to today’s announcement. We are excited to begin this next step of our development phase, and look forward to sharing quantifiable results in the near future.
http://techstockinsider.com/lexington-biosciences-lxgtf-lnb-engages-clinical-research-organization/?utm_medium=Social&utm_source=TSI_Social_Link&utm_campaign=TSI_Social_1130
Great company engaged!! : Diablo Clinical Research has specialized in clinical research for over 22 years. Founded in 1995, Diablo’s team has conducted over 600 studies with thousands of patients and in the process, has assembled a database comprising over 15,000 patients who have either completed a study, are currently enrolled in a study, or have expressed interest in future clinical study participation. The firm has 4 MDs on staff with specialties in endocrinology, internal medicine, and cardiology. Find out more at: www.diabloclinical.com.
LXGTF Engages Clinical Research Organization recently!
“WITH TODAY’S (11/30/17) ANNOUNCEMENT (LXGTF)’S PLANS ARE NOW ADVANCING TO INITIATE COMMENCEMENT OF A PILOT CLINICAL RESEARCH STUDY DESIGNED TO BEGIN GATHERING THE FOUNDATIONAL DATASET AIMED AT SUPPORTING FDA CLEARANCE.”
VANCOUVER, BC–(Marketwired – Nov 30, 2017) – Lexington Biosciences, Inc. ( CSE : LNB ) ( OTCQB : LXGTF ) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to announce the engagement of San Francisco Bay Area-based Diablo Clinical Research to conduct its upcoming HeartSentry pilot clinical studies.
Hellooo, ADAC is 80% TODAY!!!!!!!!!!!!!
ADAC is 80% TODAY!!!!!!!!!!!!!
80% ??? is this some mistake??? wooow
Breaking the RESSISTENCE!!!
ONE OF THE MANY STEPS BEFORE OTHERS! Endothelial function measurement predicts when arteries are vulnerable to developing atherosclerosis
WHY is LXGTF better? Knowing the core health of the cardiovascular system is critical to preventing future heart attacks and strokes
• Monitoring cardiovascular health changes over time is key to prevention via lifestyle modification, physician care and ongoing monitoring.
• Traditional measures of blood pressure and cholesterol measurements are only partial indicators of cardiovascular health.
The undeniable FACTS ARE: Undiagnosed Cardiovascular Disease Is a Killer
• 1 in 3 deaths annually are caused by heart disease
and stroke.
• 1.5 million people suffer heart attacks annually in
the U.S.
• Nearly 1/3 of the deaths could be prevented
through proactive changes in lifestyle habits.
• Often the FIRST SYMPTOM of coronary artery
disease is a heart attack.
What a point: Blood pressure monitor market forecast to exceed $2.6 billion by 2020
LXGTF is potential 50 Billion Dollar Industry Penny Stock to Watch!
Read More here:
https://t.co/4nL5f2LtnQ
LXGTF is potential 50 Billion Dollar Industry to Watch!
Read More here:
https://t.co/4nL5f2LtnQ
ADAC is something to consider!
LXGTF is realy bullish, breaking .48, watch it!
THE TIME IS RIGHT! The company plans to release a beta version and testing site for their online retail space within the next two weeks and hopes to have the coin in place on BitTraderLive.com by early 2018. The Company has allowed a portion of the site to go live to offer a preview of what will be brought to the market. The site is located at www.Cryx.shop .
Hello everybody!
I think that now is the time
here we go again, green, breaking .48
GREAT ARTICLE RECENTLY RELEASED
https://insiderfinancial.com/lexington-bioscien-otcmktslxgtf-venturing-into-fortune-500-territory
LXGTF engages Diablo research for next step in FDA clearance..
https://finance.yahoo.com/news/lexington-biosciences-engages-clinical-research-140000876.html
LXGTF Management Team:
https://lexingtonbiosciences.com/company/management/
Don't forget the amazing LXGTF video: https://vimeo.com/183611304
ARE YOU NEW HERE? Start your dd from LXGTF website:
https://lexingtonbiosciences.com/
LXGTF simplify and save lives!!! Current Standards are Complicated and Expensive !!!
• Gold standard - ULTRASOUND
• Measurement directly views arterial diameter
changes
• Only at specialized diagnostic centers
• Requires trained ultrasonographer
• Expensive capital equipment needed
• Alternative method - ENDOPAT
• Measurement uses a fingertip blood oxygen
sensor and laptop computer.
• Only at specialized diagnostic centers
• Requires trained technician
Currently only used in specialized research centers by highly trained staff
Good morning dear LXGTF friends! Wake up for the new great day :)
Good green closure!